Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes

This publication has 43 references indexed in Scilit:

• Functional and molecular evidence of myelin‐ and neuroprotection by thyroid hormone administration in experimental allergic encephalomyelitis
  Neuropathology and Applied Neurobiology, 2012
• Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
  Annals of Neurology, 2011
• Dissecting structure–function interactions in acute optic neuritis to investigate neuroplasticity
  Human Brain Mapping, 2009
• Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination
  Experimental Neurology, 2008
• Epilepsy and Medication Effects on the Pattern Visual Evoked Potential*
  Documenta Ophthalmologica, 2005
• Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test
  Multiple Sclerosis Journal, 2001
• New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis
  Multiple Sclerosis Journal, 2000
• Effects of Elevated Triiodothyronine on Cognitive Performance and Mood in Healthy Subjects
  Neuropsychobiology, 1994
• Decreased Serum C-Peptide/Insulin Molar Ratios After Oral Glucose Ingestion in Hyperthyroid Patients
  Diabetes Care, 1984
• Effect of Demyelination on Conduction in the Central Nervous System
  Nature, 1969